Novartis DRC Basic human research study of novel glaucoma endpoints and identification of optimal patient populations for neuroprotection trials
Research Grant
Awarded By
Novartis Pharma AG
Start Date
March 18, 2020
End Date
May 30, 2025
Awarded By
Novartis Pharma AG
Start Date
March 18, 2020
End Date
May 30, 2025